By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – UK-based Informatics firm Dotmatics said today that drug maker Pharmaxis will use its data-mining platform to manage its preclinical research data.

Dotmatics' Browser is an interactive dashboard for integrating and viewing research data from disparate sources, and its Vortex application offers predictive analytics, and data visualization and analysis applications.

Financial terms of the agreement were not released.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.